Top Markets
Coin of the day
Orexo AB Orexo AB

Orexo AB

ORX
Classement en actions #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Prix de l'action
$1.58
Capitalisation boursière
$55.48M
Changement (1 jour)
0.86%
Changement (1 an)
-28.33%
Pays
SE
Échange Orexo AB (ORX)

Catégorie

Historique des divisions d’actions pour Orexo AB (ORX)
L’action Orexo AB (symbole : ORX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 21, 2026.
Une action ORX achetée avant le Aug 21, 2026 équivaudrait aujourd’hui à 0 actions ORX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
0 -
US
0 -
SE
0 -
FR
0 -
US
7 x40
HK